Dna Group (T.R.) Ltd (TLV:DNA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 103.70
+5.00 (5.07%)
May 13, 2025, 5:24 PM IDT
Dna Group (T.R.) Market Cap
Dna Group (T.R.) has a market cap or net worth of 121.56 million as of May 13, 2025. Its market cap has increased by 3.57% in one year.
Market Cap
121.56M
Enterprise Value
53.25M
Revenue
306.00K
Ranking
n/a
PE Ratio
5.51
Stock Price
103.70
Market Cap Chart
Since December 3, 2007, Dna Group (T.R.)'s market cap has increased from 31.81M to 121.56M, an increase of 282.12%. That is a compound annual growth rate of 7.98%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 73.61B |
| Danel (Adir Yeoshua) | 2.35B |
| Kamada | 1.39B |
| Bait Bakfar | 1.15B |
| Novolog (Pharm-Up 1966) | 779.55M |
| SofWave Medical | 722.24M |
| Ilex Medical | 680.80M |
| BrainsWay | 586.43M |